The intraocular lens (IOL) market is expected to register a growth rate of nearly 5% during the forecast period, 2018-2023. Intraocular lenses (IOLs) are implantable medical devices used for vision correction. Increasing cases of diabetes and associated cataract and diabetic retinopathy complications are expected to boost the global market. Increase in ocular conditions, such as cataract and diabetic retinopathy, across the world, is a major aspect assisting the market growth.  According to the National Eye Institute, the United States recorded 7.7 million diabetic retinopathy cases and 24 million cataract cases, which is estimated to reach 11.3 million and 38 million, respectively, by 2030.  Geographically, the market studied is segmented into North America, Europe, Asia-Pacific, Middle East & Africa, and South America. Each region has been divided further into major countries, for which market size and forecast value are provided separately. Other countries in that particular region are covered under the “Rest of that region”, for which the market size and forecast value are provided as a whole.  A holistic study of the market studied has been carried out by incorporating various factors, extending from country-specific demographic conditions and business cycles to market-specific microeconomic influences, which were needed to analyze future trends.  The research uncovers many paradigm shifts in the market studied, in terms of regional competitive advantage and dynamics, primarily with respect to services.

Although the global pharma & healthcare sector is dominated by large multinational companies, mainly from the developed countries, Latin America has been quickly catching up in building a domestic pharmaceutical production base and expanding the access of the population to innovative medical treatment and quality health services. This was propelled by active government policies directed towards scientific knowledge generation and technology adoption, alignment of the regulation with the best international practices, and infrastructure enhancements in all stages of the healthcare process – from prevention and treatment to rehabilitation and palliative care. Private capitals also played a role, supported by the opening of the pharma and healthcare markets to foreign investors in most countries and the liberalisation of foreign trade in raw inputs, pharmaceuticals and medical devices. From the demand side, the ageing of the population and the rapid shift towards the epidemiological profile of developed countries have resulted in an increasing demand for complex medical treatment, innovative drugs and vaccines.

Visual impairment is a broad term, which involves moderate or severe vision loss or complete blindness. It is a global health concern that has a negative impact on both physical and mental health. Preventive blindness, which was considered among common ailments, will soon emerge as a major challenge to the global healthcare system. Blindness and visual impairment necessitate significant costs as they not only constitute high productivity loss but also increase the burden on healthcare spending significantly. According to the IAPB, about 36 million people were categorized as blind, and about 217 million people were estimated to suffer from moderate to severe visual impairment (MVSI) in 2014. According to the WHO, uncorrected errors, especially myopia, hyperopia, or astigmatism, constituted 43% of overall visual impairment cases in 2014.

De-oiled lecithin is a dry form of lecithin and has multi-functional properties across various industries, food, feed, pharma, and personal care. The global de-oiled lecithin market is expected to witness significant growth during the forecast period due to rise in awareness among consumers regarding the ill effects of consumption of GMO food products. Moreover, increase in demand for green and organic food products boosts the growth of the market.

The report covers a study of the global protein supplement market and provides the detailed analysis of the market trends, future estimations, and a thorough study of the global market based on type, form, source, distribution channel, and region. By type, the market is segmented into casein, whey protein, egg protein, soy protein, and others. Based on form, the market is segmented into powder, RTD liquid and protein bars. On the basis of source, it is segmented into animal and plant. Based on distribution channel, the market is segmented into supermarkets/hypermarkets, online, chemist/drugstore, nutrition store, health food store, specialist sports store, and others. Based on region, the market is analyzed across North America (U.S., Canada, and Mexico), Europe (UK, Germany, France, Spain, Italy, and Rest of Europe), Asia-Pacific (China, Japan, India, Australia, South Korea, and Rest of Asia-Pacific), and LAMEA (Brazil, KSA, South Africa and Rest of LAMEA). The study highlights Porter’s five forces analysis to determine the factors affecting the market growth. These factors include raw material prices, intense competition, end users, manufacturers, and suppliers. To understand the market movement, drivers, restraints, and opportunities are explained in the report.

On the basis of product type, the market has been segmented into orange, corn mint, eucalyptus, citronella peppermint, lemon, clove leaf, lime, spearmint, lavender and others. Orange essential oil emerged as the largest product segment in 2017 and accounted for 28.3% of the market volume. Orange essential oil is widely used in herbal medicines and aromatherapy.

Mammography refers to a standard diagnostic and screening technique to screen breast tissues for the presence of malignant tumor. The process involves usage of low-energy Xrays for early detection of breast cancer. On the basis of technology used, the mammography market can mainly be classified as film-screen or digital one.

The Indian healthcare Industry has undergone significant transformation over the past three decades. From one dominated by public sector hospitals, it has shifted to being dominated by private hospitals in a response to the changing healthcare needs of the population. The private sector that dominates the secondary and tertiary healthcare segments, accounts for around 70% of total health care spending in India as of FY2018. Approximately 75% of all hospitals and 40% of total hospital beds - particularly in the secondary and tertiary healthcare segments - are owned and operated by the private sector. During FY2014-FY2018, India’s hospital sector grew at a CAGR of 8% to USD 87bn in FY2018. The key drivers of healthcare services in India are the increase in patient population and the resulting higher spending on healthcare services.

The demand for minimally invasive procedures/surgeries (MIS) is on a rise. These procedures result in lesser trauma to the patients and quicker recovery than invasive procedures. The research results published by manufacturers (Ethicon Endo-Surgery, Inc.) suggest that minimally invasive surgeries are rapidly replacing open/invasive surgeries, owing to the following factors

The global artificial insemination market size was valued at around USD 1,514.6 million in 2018 and is expected to grow at a CAGR of 8.4% over the forecast period. Over the past few years, the rate of infertility has been increasing across the globe. According to WHO survey of 2010, around 10% of women are directly or indirectly affected by infertility. In addition, National Institutes of Health reported that infertility affects around 12% of couples of reproductive age.

Pharmacogenomics falls in the branch of precision medicine and deals with the drug response in an individual based on his/her genetic profile. It hence allows doctors to devise a tailor-made prescription for patients suffering from life-threatening diseases such as cancer, neurological, and cardiovascular disorders. Furthermore, use of pharmacogenomics-based diagnostic tests facilitates improved drug response, reduced probability of drug failure, enhanced drug efficiency, and higher survival rate in case of cancer. Pharmacogenomics majorly includes the use of bioinformatics tools and several molecular biology techniques to determine the reason for an individual patient's illness at a molecular level. Furthermore, treatment is followed with the use of required dosage to address an individual patient's illness. This report takes into consideration the revenue generated by the sales of instruments, reagents, software, solutions, services, and therapeutics used to practice pharmacogenomics.

The healthcare payer services market is categorized into outsourcing service, application, end user, and geographical segments. The outsourcing services that are covered in our study include Business Process Outsourcing (BPO), Knowledge Process Outsourcing (KPO), and Information Technology Outsourcing (ITO). Various applications in our study include claim management, integrated front & back office operations, member management services, provider management services, billing & accounts management services, analytics & fraud management services, and HR services. Private and public are two types of payers included in this report. The global healthcare payer services market is expected to grow at a CAGR of 8.1% from 2016 to 2024.

The revenues generated through the sale of proteomics instruments, reagents, and services are considered in the scope of the current report. However, revenues associated with related technologies such as transcriptomics and genomics are not considered in the report.

The pharmaceutical market in the Czech Republic is strongly competitive with numerous foreign companies. There were 90 active companies in 2017, up from 80 in 2014. Foreign players dominate the market due to the high costs related to drug production, especially that of patented drugs. The pharmaceutical industry is among the sectors with high R&D costs, which accounted for about 15%- 20% of the annual revenues of the sector, according to the Ministry of Industry and Trade.

The cancer diagnostics market has been segmented on three levels: Screening types, application, and geography. Screening types comprises laboratory tests, genetic tests, imaging, endoscopy, biopsy, and others. The application segment is categorized into breast, colorectal, cervical, lung, cervical, prostate, skin, blood, kidney, liver, pancreatic, ovarian cancers, and others. Key regions includes North America, Europe, Asia Pacific, Latin America, and MEA.